Sathitsamitphong Lalita, Natesirinilkul Rungrote, Choeyprasert Worawut, Charoenkwan Pimlak
Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Case Rep Hematol. 2019 Nov 5;2019:8264689. doi: 10.1155/2019/8264689. eCollection 2019.
Orbital involvement is one of the extramedullary manifestations in acute leukemia. It is common in acute myeloid leukemia, but rare in acute lymphoblastic leukemia (ALL). We described a 3-year-old girl who presented with progressive proptosis of the right eye and was later diagnosed with precursor B-cell ALL. Initial blood count showed Hb 6.9 g/dL, WBC 42,000/mm, lymphoblast 50%, and platelet count 185,000/mm. Bone marrow aspiration revealed 90% lymphoblasts with positivity for CD10, CD19, CD20, CD22, and HLA-DR markers. Computed tomography (CT) scan of the brain and orbit revealed a homogeneous enhancing mass involving the right orbit with intracranial extension. The cytogenetic study showed 46,XX chromosomes. After 4 weeks of induction chemotherapy for very high-risk ALL, although the bone marrow was in remission, the proptosis was partially resolved. CT scan confirmed a decrease in size of the right orbital mass and degree of intracranial extension. Unfortunately, the patient abandoned the treatment after the induction chemotherapy. The actual incidence of orbital involvement in ALL is unknown. Previous case reports describe diverse manifestations of orbital involvement in ALL. The involvement may be unilateral or bilateral, may occur at first diagnosis or at relapse, and may be seen in isolation or with other systemic symptoms. There is no standard treatment protocol. Chemotherapy with or without radiotherapy is generally suggested. The role of upfront hematopoietic stem cell transplantation remains inconclusive. The previously reported prognosis of ALL with orbital involvement is poor.
眼眶受累是急性白血病的髓外表现之一。在急性髓系白血病中较为常见,但在急性淋巴细胞白血病(ALL)中罕见。我们报道了一名3岁女孩,她出现右眼进行性眼球突出,后来被诊断为前体B细胞ALL。初始血常规显示血红蛋白6.9 g/dL,白细胞42,000/mm,原始淋巴细胞50%,血小板计数185,000/mm。骨髓穿刺显示90%原始淋巴细胞,CD10、CD19、CD20、CD22和HLA-DR标记呈阳性。脑部和眼眶计算机断层扫描(CT)显示一个均匀强化的肿块累及右侧眼眶并向颅内延伸。细胞遗传学研究显示为46,XX染色体。在对极高危ALL进行4周诱导化疗后,尽管骨髓缓解,但眼球突出部分缓解。CT扫描证实右侧眼眶肿块大小及颅内延伸程度减小。不幸的是,患者在诱导化疗后放弃治疗。ALL眼眶受累的实际发生率尚不清楚。既往病例报告描述了ALL眼眶受累的多种表现。受累可能是单侧或双侧,可在初诊时或复发时出现,可单独出现或伴有其他全身症状。目前尚无标准治疗方案。一般建议进行化疗,可联合或不联合放疗。 upfront造血干细胞移植的作用仍不明确。既往报道的ALL眼眶受累预后较差。